Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Clinical grade mesenchymal stem cells transdifferentiated under xenofree conditions alleviates motor deficiencies in a rat model of Parkinson's disease.

Shetty P, Ravindran G, Sarang S, Thakur AM, Rao HS, Viswanathan C.

Cell Biol Int. 2009 Aug;33(8):830-8. doi: 10.1016/j.cellbi.2009.05.002. Epub 2009 May 22.

PMID:
19465139
2.

Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.

Levy YS, Bahat-Stroomza M, Barzilay R, Burshtein A, Bulvik S, Barhum Y, Panet H, Melamed E, Offen D.

Cytotherapy. 2008;10(4):340-52. doi: 10.1080/14653240802021330.

PMID:
18574767
3.

Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease.

Bahat-Stroomza M, Barhum Y, Levy YS, Karpov O, Bulvik S, Melamed E, Offen D.

J Mol Neurosci. 2009 Sep;39(1-2):199-210. doi: 10.1007/s12031-008-9166-3. Epub 2009 Jan 6.

PMID:
19127447
4.

Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson's disease.

Li M, Zhang SZ, Guo YW, Cai YQ, Yan ZJ, Zou Z, Jiang XD, Ke YQ, He XY, Jin ZL, Lu GH, Su DQ.

Neurochem Res. 2010 Oct;35(10):1522-9. doi: 10.1007/s11064-010-0211-6. Epub 2010 Jul 24.

PMID:
20658188
5.

Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease.

Offen D, Barhum Y, Levy YS, Burshtein A, Panet H, Cherlow T, Melamed E.

J Neural Transm Suppl. 2007;(72):133-43.

PMID:
17982886
6.

Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.

Levy YS, Stroomza M, Melamed E, Offen D.

J Mol Neurosci. 2004;24(3):353-86. Review.

PMID:
15655260
7.

One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons.

Geeta R, Ramnath RL, Rao HS, Chandra V.

Biochem Biophys Res Commun. 2008 Aug 22;373(2):258-64. doi: 10.1016/j.bbrc.2008.06.022. Epub 2008 Jun 17.

PMID:
18565328
8.

Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease.

Jensen P, Pedersen EG, Zimmer J, Widmer HR, Meyer M.

Brain Res. 2008 Jul 7;1218:13-20. doi: 10.1016/j.brainres.2008.04.039. Epub 2008 Apr 26.

PMID:
18513704
9.

Isolation and characterization of mesenchymal stem cells derived from bone marrow of patients with Parkinson's disease.

Zhang Z, Wang X, Wang S.

In Vitro Cell Dev Biol Anim. 2008 May-Jun;44(5-6):169-77. doi: 10.1007/s11626-008-9093-1. Epub 2008 Apr 10.

PMID:
18401666
10.

Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.

Murrell W, Wetzig A, Donnellan M, FĂ©ron F, Burne T, Meedeniya A, Kesby J, Bianco J, Perry C, Silburn P, Mackay-Sim A.

Stem Cells. 2008 Aug;26(8):2183-92. doi: 10.1634/stemcells.2008-0074. Epub 2008 Jun 5.

11.

Bone marrow stromal cells as replacement cells for Parkinson's disease: generation of an anatomical but not functional neuronal phenotype.

Thomas MG, Stone L, Evill L, Ong S, Ziman M, Hool L.

Transl Res. 2011 Feb;157(2):56-63. doi: 10.1016/j.trsl.2010.11.001. Epub 2010 Dec 5.

PMID:
21256457
12.

Dopaminergic neuronal differentiation protocol for human mesenchymal stem cells.

Trzaska KA, Rameshwar P.

Methods Mol Biol. 2011;698:295-303. doi: 10.1007/978-1-60761-999-4_22.

PMID:
21431527
13.

Expression of dopamine-associated genes on conjunctiva stromal-derived human mesenchymal stem cells.

Nadri S, Soleimani M, Mobarra Z, Amini S.

Biochem Biophys Res Commun. 2008 Dec 12;377(2):423-8. doi: 10.1016/j.bbrc.2008.09.148. Epub 2008 Oct 11.

PMID:
18851950
14.

The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model.

Cai J, Donaldson A, Yang M, German MS, Enikolopov G, Iacovitti L.

Stem Cells. 2009 Jan;27(1):220-9. doi: 10.1634/stemcells.2008-0734.

15.
16.

Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease.

O'Keeffe FE, Scott SA, Tyers P, O'Keeffe GW, Dalley JW, Zufferey R, Caldwell MA.

Brain. 2008 Mar;131(Pt 3):630-41. doi: 10.1093/brain/awm340. Epub 2008 Jan 17.

PMID:
18202103
17.

Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro.

Jin GZ, Cho SJ, Choi EG, Lee YS, Yu XF, Choi KS, Yee ST, Jeon JT, Kim MO, Kong IK.

Cell Biol Int. 2008 Nov;32(11):1433-8. doi: 10.1016/j.cellbi.2008.08.014. Epub 2008 Aug 20.

PMID:
18778785
18.

Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases.

Sadan O, Shemesh N, Cohen Y, Melamed E, Offen D.

Isr Med Assoc J. 2009 Apr;11(4):201-4.

19.

Dopaminergic differentiation of human mesenchymal stem cells--utilization of bioassay for tyrosine hydroxylase expression.

Kan I, Ben-Zur T, Barhum Y, Levy YS, Burstein A, Charlow T, Bulvik S, Melamed E, Offen D.

Neurosci Lett. 2007 May 23;419(1):28-33. Epub 2007 Apr 13.

PMID:
17475405
20.

Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.

Gu S, Huang H, Bi J, Yao Y, Wen T.

Brain Res. 2009 Feb 27;1257:1-9. doi: 10.1016/j.brainres.2008.12.016. Epub 2008 Dec 16.

PMID:
19111525

Supplemental Content

Support Center